supply of injections & i v fluids (2019-20) , name of the item : , anti-gas gangrene serum ( aggs ) 30000 i . u . inj , atropine inj infusion 30mg/50ml , cyclosporine 100 mg/ml - 50 ml inj , desferroxamine 500 mg inj , digoxin 0 . 25 mg/ml inj , ethacridine lactate 1 mg/ ml inj , etophyilline 110 mg +theophylline 27 mg/ml inj , hepatitis -b- vaccine genetically engineered 20mcg/ml inj , highly purified human nph /isophane insulin inj . ( intermediate acting ) 40 i . u . /ml , insulin lispro mix 25/75 pen with needle pack size - 1 pen , human insulin analog-lispro inj 100 u/ml ( rapid acting ) , hyaluronidase 1500 iu powder for solution for injection , hydroxy propyl methyl cellulose usp 2% in sterile isonic base pfs inj , ketamine hydrochloride inj 10mg/ml , lignocaine 4% topical , lignocaine + dextrose 5% spinal heavy inj , lorazepam 2 mg/ ml inj , multivitamin inj nfi each ml contain: vitamin b 1 ip 10mg vitamin b2 ip 2mg vitamin b6 ip 2mg niacinamide ip 100mg d-panthenol ip 5mg , ondansetron 4 mg/ml inj , parnaparine sodium 6400 iu axa inj , pethidine hydrochloride 50 mg inj , protamine sulphate 50 mg/ 5ml inj , tetanus toxoid inj , tirofiban 50mcg/ml inj , dexmedetomidine 100mcg/ml inj , dexmedetomidine 100mcg /ml inj , non-ionic 350 iopromide / ioversol / iohexol / iopamidol 350 mg/ml , non -ionic 350 iopromide / ioversol /iohexol / iopamidol 350 mg/ml , non- ionic 300 iopromide/ioversol/ iohexol / iopamidol 300 mg/ml , non- ionic 300 iopromide/ioversol/ iohexol / iopamidol 300 mg/ml , oral contrast sodium diatrizoate meglumine diatrizoate ( iodine content 370 mg/ml ) 370 mg/ml , mri contrast media inj . gadolinium / gadoversetamide / gadodiamide / gadopentetate 0 . 5 molar 0 . 5 mmol / ml , premix insulin 30:70 injection recombinant human insulinbiphasic 30% , regular 70% 100 iu/ml , inj . hyluronidase 2ml , inj dulaglutide 1 . 5mg/vial , oxytocin inj 10 iu 1 ml 2 ampule , promethazine inj 50mg/ml , inj . tenecteplase 40mg , inj . vitamin k with disposable syringe starile with needle 1 inch 2 ml , inj . quinine & artesunate , inj lung surfactant , inj lung surfactant , inj non ionic contrast for intravascular use iodine concentration 350-370 mg /ml 100 ml vial or scan bags packing may be accepted subject to provision of injector at free of cost , inj non ionic contrast for intravascular use iodine concentration 400 mg/ml ( 100 ml bottle ) , inj . gadolinium base contrast for m . r . i for pediatrics use , inj . gadolinium base contrast for m . r . i use liver /liver specific ( should have hepatobiliary excretion , inj . gadolinium best contrast for m . r . i for general use , inj . gadolinium base contrast for m . r . i use angiography , plasma substitute containing dextran ( mol . wt . 40 , 000 ) with 5% dextrose and 0 . 9% sodium chloride ( w/v ) , 500 ml bottle , hydroxyethyl starch ( 200/0 . 5 ) 6 % , 500 ml bottle , low molecular weight heparin 0 . 4 iu ( enoxaparin ) , 0 . 4 ml